PMID- 15578884 OWN - NLM STAT- MEDLINE DCOM- 20050520 LR - 20210527 IS - 1543-2165 (Electronic) IS - 0003-9985 (Linking) VI - 128 IP - 12 DP - 2004 Dec TI - The value of fluorescence in situ hybridization and polymerase chain reaction in the diagnosis of B-cell non-Hodgkin lymphoma by fine-needle aspiration. PG - 1395-403 AB - CONTEXT: Molecular genetic analyses have been predicted to improve the diagnostic accuracy of fine-needle aspiration of B-cell non-Hodgkin lymphoma. OBJECTIVE: To determine the value of routine molecular genetic assays, polymerase chain reaction (PCR) and fluorescence in situ hybridization (FISH), in the diagnosis of B-cell non-Hodgkin lymphoma by fine-needle aspiration (FNA). DESIGN: A multiparametric method, including cytology, flow cytometry, PCR, and FISH, was prospectively evaluated in the diagnosis of B-cell non-Hodgkin lymphoma by FNA. Aspirates from 30 consecutive patients with suspected hematolymphoid malignancies were collected. All aspirates were triaged through a uniform program including cell-size analysis, B- and T-cell clonality studies, flow cytometric immunophenotyping, and bcl-1 and bcl-2 gene rearrangements by PCR and FISH. After completion of FNA evaluations, FNA results were compared with diagnoses from prior or subsequent surgical biopsies. RESULTS: Monoclonal B-cell populations were detected in 18 of 20 B-cell non-Hodgkin lymphomas by flow cytometry and PCR. bcl-1 gene rearrangement was detected in 2 of 2 cases of mantle cell lymphoma. bcl-2 rearrangement was detected in 5 cases including 4 of 4 low-grade follicular lymphomas and 1 transformed follicular lymphoma. By incorporating the results of molecular genetic and ancillary diagnostics, a definitive classification was reached in 12 cases of B-cell non-Hodgkin lymphoma by FNA, including all cases of low-grade follicular lymphoma (4/4) and mantle cell lymphoma (2/2) and approximately 50% of small lymphocytic lymphoma (2/4) and large B-cell lymphoma (4/8). Ten of the 12 cases with a final classification reached by FNA had either prior or follow-up surgical biopsies, and all 10 cases showed agreement between the diagnoses rendered on FNA and surgical biopsies. CONCLUSIONS: With proper handling and management of specimens, FNA can routinely provide samples adequate for molecular genetic studies, in addition to cytomorphology and flow cytometry, making it possible to consistently render accurate and definitive diagnoses in a subset of B-cell non-Hodgkin lymphomas. By incorporating FISH and PCR methods, FNA may assume an expanded role for the primary diagnosis of B-cell non-Hodgkin lymphoma. FAU - Safley, Anne M AU - Safley AM AD - Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA. FAU - Buckley, Patrick J AU - Buckley PJ FAU - Creager, Andrew J AU - Creager AJ FAU - Dash, Rajesh C AU - Dash RC FAU - Dodd, Leslie G AU - Dodd LG FAU - Goodman, Barbara K AU - Goodman BK FAU - Jones, Claudia K AU - Jones CK FAU - Lagoo, Anand S AU - Lagoo AS FAU - Stenzel, Timothy T AU - Stenzel TT FAU - Wang, Weihua AU - Wang W FAU - Xie, Bill AU - Xie B FAU - Gong, Jerald Z AU - Gong JZ LA - eng PT - Journal Article PL - United States TA - Arch Pathol Lab Med JT - Archives of pathology & laboratory medicine JID - 7607091 SB - IM MH - Adult MH - Aged MH - Aged, 80 and over MH - Biopsy, Fine-Needle MH - Cytodiagnosis/trends MH - Female MH - Flow Cytometry/trends MH - Humans MH - In Situ Hybridization, Fluorescence/methods/*trends MH - Lymphoma, B-Cell/*diagnosis MH - Lymphoma, Non-Hodgkin/*diagnosis MH - Male MH - Middle Aged MH - Molecular Diagnostic Techniques/trends MH - Polymerase Chain Reaction/methods/*trends MH - Prospective Studies EDAT- 2004/12/08 09:00 MHDA- 2005/05/21 09:00 CRDT- 2004/12/08 09:00 PHST- 2004/12/08 09:00 [pubmed] PHST- 2005/05/21 09:00 [medline] PHST- 2004/12/08 09:00 [entrez] AID - OA4109 [pii] AID - 10.5858/2004-128-1395-TVOFIS [doi] PST - ppublish SO - Arch Pathol Lab Med. 2004 Dec;128(12):1395-403. doi: 10.5858/2004-128-1395-TVOFIS.